http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2437709-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_268fdb29c49dd4aa5e848ab55a2e09fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6850847e8a7f863e68c1e64eee7b439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b31568037fbbc1bbeef3b6ec26068108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871c4d170390d8df80a7f4fa8a762923 |
publicationDate | 2005-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2437709-A1 |
titleOfInvention | Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events |
abstract | This invention relates to a method of treating and preventing vascular events and circulatory disorders in a patient in need thereof, especially in a patient at risk for said indications, using dipyridamole in combination with acetylsalicylic acid (ASA) and an angiotensin II antagonist, corresponding pharmaceutical compositions, and the use of dipyridamole for the manufacture of a corresponding pharmaceutical composition comprising a combination of dipyridamole, acetyl salicylic acid and an angiotensin II antagonist. |
priorityDate | 2003-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.